MSR1 was also shown to affect CML development by regulating the PI3K-AKT pathway and β-Catenin, which suggesting that MSR1 suppresses LSCs and CML development [41]. This evidence concerns the gene MSR1 and chronic myelogenous leukemia, BCR-ABL1 positive.